Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Online Pharmacy...

    Online Pharmacy Netmeds Acquires Hyperlocal Medicine Delivery Startup Pluss

    Written by supriya kashyap kashyap Published On 2016-11-25T11:23:32+05:30  |  Updated On 17 Aug 2021 12:36 PM IST

    Online pharmacy Netmeds has acquired Delhi-based hyperlocal delivery startup for medicine, healthcare and wellness products, Pluss for an undisclosed amount. The company was in advanced talks to complete the acquisition earlier in October this year.


    Post the acquisition, Pluss will continue to run its operations and facilities in Delhi, but will merge with Netmeds as one entity. A few of the senior official's from Pluss' team will relocate to Chennai and will work from Netmeds' office.


    Launched in 2015 by Atit Jain, Madhulika Pandey, and Tarun Lawadia, Pluss is an on-demand medicine delivery startup that provides its services by placing orders through calls, Whatsapp or the Pluss website. In addition to delivering medicines, Pluss also offers baby care, pet care, personal wellness, and daily essential products. It also has an in house delivery team called, 'Pluss Men'.


    In November 2015, it raised $1 Mn in a Pre-Series A round of funding led by IDG Ventures India, M&S partners, and Powerhouse Ventures. Before that, the startup had reportedly raised $200K as Seed funding from angel investors including Kunal Bahl and Anand Chandrasekaran among others.


    The startup currently provides its services in Delhi NCR and Hyderabad. As per an official statement, post the deal, Netmeds will be able to double its penetration in the NCR region.


    Commenting on the acquisition, Pradeep Dadha, CEO, Netmeds said: "This acquisition makes a lot of sense for us since it allows us to scale quicker, and shorten the delivery interval and improve efficiencies in Tier I Metros. This has become even more incumbent upon us, as demonetisation and the move to a cashless economy combined with a robust digital mobile consumerism, fuels our growth."


    Chennai-based Netmeds was founded in 2010 by Pradeep Dadha. It is a licensed pharmacy marketplace that offers authenticated prescription and over-the-counter (OTC) medicine along with other health products. Users can upload their prescription that is examined by the company's pharmacists to assist with proper dosage, duration, and other points of validity before completing the order.


    In October 2015, it raised $50 Mn led by OrbiMed, a healthcare-focussed investment firm. Users can order medicines through NetMeds' mobile app as well available on both iOS and Android platforms.


    Other players operating in this space include Medfinder, 1mg, Pharmeasy, MyMedisyn, Medist, and Mera Medicare.

    Anand ChandrasekaranAtit JainHyperlocal Medicine DeliveryKunal BahlMadhulika PandeyNetmedsOnline PharmacyOrbiMedPradeep DadhaStartup PlussTarun Lawadia
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok